Lucid Diagnostics (LUCD) Preferred Shares (2023 - 2026)

Lucid Diagnostics (LUCD) has 4 years of Preferred Shares data on file, last reported at $10.1 million in Q1 2026.

• For the quarter ending Q1 2026, Preferred Shares fell 81.38% year-over-year to $10.1 million; the trailing twelve-month figure through Mar 2026 stood at $10.1 million (down 81.38% YoY), and the FY2025 full-year result was $54.3 million, changed 0.27% from the prior year.
• Preferred Shares for Q1 2026 stood at $10.1 million, down from $54.3 million in the prior quarter.
• Across five years, Preferred Shares topped out at $55.9 million in Q2 2024 and bottomed at $10.1 million in Q1 2026.
• The 4-year median for Preferred Shares is $54.3 million (2025), against an average of $38.3 million.
• The widest annual swing landed in 2024, when Preferred Shares soared 310.41%; it then slumped 81.38% in 2026.
• A 4-year view of Preferred Shares shows it stood at $18.6 million in 2023, then surged by 192.18% to $54.4 million in 2024, then slipped by 0.27% to $54.3 million in 2025, then tumbled by 81.33% to $10.1 million in 2026.
• The last three Preferred Shares figures came in at $10.1 million (Q1 2026), $54.3 million (Q4 2025), and $54.3 million (Q3 2025), per Business Quant data.

Peer Comparison